Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis
2020 · Brain · 89 citations
https://doi.org/10.1093/brain/awaa251
M
Mattia Fonderico
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
629
Citations
15
h-index
17
i10-index
Mattia Fonderico is an academic researcher from Azienda Usl Toscana Centro. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Polyomavirus and related diseases. The author has an h-index of 15, co-authored 24 publications.
ORCID: 0000-0002-1716-5579Papers by this author
worksMultiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients
2018 · Frontiers in Neurology · 24 citations
https://doi.org/10.3389/fneur.2018.01080
Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis
2021 · Brain Sciences · 16 citations
https://doi.org/10.3390/brainsci11111444
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat